Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease

NCT00058773 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Disease
Non-Hodgkins Lymphoma

Interventions

DRUG: Infusion of EBV Specific Cytotoxic T-Lymphocytes

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]